Alcon (ALC) has released an update.
Alcon, a global leader in eye care, has reported a strong financial performance in the second quarter of 2024 with sales reaching $2.5 billion, marking a 3% increase from the previous year, and a notable 32% increase in diluted EPS. The company has also generated impressive free cash flow growth, up by 253%. These results reflect Alcon’s successful demand generation for its implantables and contact lenses and set the stage for upcoming product launches anticipated to fuel further growth.
For further insights into ALC stock, check out TipRanks’ Stock Analysis page.
